{
  "id": 17872501,
  "title": "Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins",
  "url": "https://urgent.news/2026/11/02/reducing-hallucinations-in-schizophrenia-with-focused-ultrasound",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-02T22:40:06.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-hallucinations-schizophrenia-focused-ultrasound-human.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Auditory hallucinations—or hearing voices that others do not hear—affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new treatment approaches are urgently needed.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}